WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Coherus Biosciences earnings were -$130.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CHRS earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$56.6M, up 11.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CHRS reported annual earnings of $28.5M, with -112% growth.

CHRS earnings history

Current Revenue
$197.5M
Current Earnings
-$130.9M
Current Profit Margin
-66.3%

CHRS Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
31.5%

CHRS undefined

Current Company
-26.2%
Current Industry
-2.5%
CHRS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CHRS announces earnings.

CHRS undefined

Current Company
-97.17%
Current Industry
5.8%
CHRS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CHRS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CHRS-$106.54M-$130.94MN/A-$1.13
NAUT-$62.28M-$68.66MN/A-$0.54
MIST-$48.18M-$51.93MN/A-$0.78
BMEA-$124.23M-$128.63MN/A-$3.54
IOBT-$96.42M-$98.46MN/A-$1.49
View Top Biotech Stocks

Coherus Biosciences Earnings Reports & History FAQ

What were Coherus Biosciences's earnings last quarter?

On CHRS's earnings call on Invalid Date, Coherus Biosciences (NASDAQ: CHRS) reported Q1 2025 earnings per share (EPS) of -$0.49, up 153.85% year over year. Total CHRS earnings for the quarter were -$56.57 million. In the same quarter last year, Coherus Biosciences's earnings per share (EPS) was $0.91.

If you're new to stock investing, here's how to buy Coherus Biosciences stock.

Is Coherus Biosciences profitable or losing money?

As of the last Coherus Biosciences earnings report, Coherus Biosciences is currently losing money. Coherus Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$130.94 million, a 120.85% increase year over year.

What was CHRS's earnings growth in the past year?

As of Coherus Biosciences's earnings date in Invalid Date, Coherus Biosciences's earnings has grown year over year. CHRS earnings in the past year totalled -$130.94 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.